Highlights BG Medicine, Inc.

Equities

BGMD

US08861T2069

Delayed OTC Markets Other stock markets 10:36:41 2023-12-06 am EST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2016	BG Medicine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2015	CI
2016	BG Medicine Announces Board Changes	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BG Medicine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2015	16-03-31	CI
BG Medicine Withdraws 510(K) Premarket Notification for Proposed Additional Indication for the Bgm Galectin-3® Test	15-12-23	CI
BG Medicine, Inc. Amends License and Distribution Agreement for Galectin-3 with Abbott Laboratories	15-11-30	CI
BG Medicine, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015	15-11-17	CI
BG Medicine, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015	15-08-14	CI
BG Medicine, Inc. Announces First Automated Test for Galectin-3 Now Available in U.S	15-07-06	CI
BGMD Seeks Acquisitions	15-05-19	CI
BG Medicine, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Financial Guidance for 2015	15-05-14	CI
BG Medicine, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014	15-03-31	CI
BG Medicine, Inc. Announces U.S. Food and Drug Administration's 510(k) Clearance for Galectin-3 Testing	14-12-30	CI
BG Medicine, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Provides Earnings Guidance for the Full Year 2014	14-11-13	CI
BG Medicine, Inc. Reports Clinical Utility of BGM Galectin-3(R) Test for Prediction of Near-Term Rehospitalization in Patients With Heart Failure	14-03-25	CI
BG Medicine, Inc. Announces the Publication of Results of Clinical Research Study	14-01-28	CI
BG Medicine, Inc. Announces Publication of Results of an Independent Multicenter Clinical Research Trial in Europe	13-11-19	CI
BG Medicine, Inc. Announces SilverStaff Offering Galectin-3 Testing Services to its Laboratory Customers and Physicians	13-11-06	CI
BG Medicine, Inc. Announces the Publication of the Results of Clinical Research Study Conducted at the Massachusetts General Hospital	13-09-23	CI
BG Medicine, Inc. Announces Late-Breaker Oral Presentation of New Data on the BGM Galectin-3(R) Test in Heart Failure	13-05-27	CI
BG Medicine, Inc. to Launch CardioSCORE Test in Europe	13-05-09	CI
Trenton Health Team Adopts BG Medicine's BGM Galectin-3 Test	13-05-08	CI
BG Medicine, Inc. Highlights Role of Galectin-3 Testing in Combating Hospital Readmissions at the American College of Cardiology's 62nd Annual Scientific Session & Expo	13-03-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights BG Medicine, Inc.

Equities

BGMD

US08861T2069

Highlights

Filters